Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-10

Clinical Trial Update: Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports results for new travoprost formulations tested in patients with open-angle glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hypertension, Open-angle Glaucoma | Phase 2 | Status: COMPLETED